Exome Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-987
| Closed | -$305K | – | 63 |
|
|
2024
Q4 | $305K | Buy |
+987
| New | +$305K | 0.23% | 55 |
|
|
2024
Q3 | – | Sell |
-10,800
| Closed | -$3.03M | – | 74 |
|
|
2024
Q2 | $3.03M | Buy |
10,800
+2,900
| +37% | +$812K | 2.69% | 10 |
|
|
2024
Q1 | $2.11M | Sell |
7,900
-5,302
| -40% | -$1.42M | 1.81% | 19 |
|
|
2023
Q4 | $3.05M | Buy |
+13,202
| New | +$3.05M | 3.02% | 10 |
|